Evidence map›Paper›PMID 40707947›Full record

ArticleBMC medical informatics and decision making2025

Optimized feature selection and advanced machine learning for stroke risk prediction in revascularized coronary artery disease patients.

Yong Si, Armin Abdollahi, Negin Ashrafi, Greg Placencia, Elham Pishgar, Kamiar Alaei, Maryam Pishgar

Abstract read
In one paragraph

Article in BMC medical informatics and decision making, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yong SiUniversity of Southern California, Los Angeles, CA, USA.
Armin AbdollahiUniversity of Southern California, Los Angeles, CA, USA.
Negin AshrafiUniversity of Southern California, Los Angeles, CA, USA.
Greg PlacenciaCalifornia State Polytechnic University, Pomona, CA, USA.
Elham PishgarColorectal Research Center, Iran University of Medical Sciences, Iran.
Kamiar AlaeiCalifornia State University, Long Beach, CA, USA.
Maryam PishgarUniversity of Southern California, Los Angeles, CA, USA. pishgar@usc.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCoronary artery disease (CAD) remains a leading cause of global mortality, with stroke constituting a significant complication among patients undergoing coronary revascularization procedures, such as percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). Previous research has demonstrated the successful application of machine learning (ML) in predicting various postoperative outcomes, including poor prognosis following cardiac surgery and the risk of postoperative stroke. Despite these advancements, a critical gap persists in studies quantitatively linking the risk of postoperative stroke to revascularization using ML-based approaches. This study aims to address this gap by developing and validating ML models to predict the risk of stroke in CAD patients undergoing coronary revascularization, with the ultimate goal of enhancing clinical decision-making and improving patient outcomes.

methodsWe developed an ML framework to predict stroke risk in patients with CAD undergoing revascularization. A total of 5,757 patients were extracted from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. Feature selection was performed using a combination of Pearson correlation analysis, least absolute shrinkage and selection operator (LASSO), ridge regression, and elastic net. Initially, 35 features were identified based on expert opinion and a comprehensive literature review; the integrated results of the feature selection methods reduced the feature set to 14. The dataset was randomly divided into training, testing, and validation subsets with proportions of 70%, 15%, and 15%, respectively. Several ML models were evaluated, including logistic regression, XGBoost, random forest, AdaBoost, Bernoulli naive Bayes, k-nearest neighbors (KNN), and CatBoost. Model performance was assessed using the area under the receiver operating characteristic curve (AUC-ROC), accuracy, and 500 bootstrapped 95% confidence intervals (CIs) to ensure robust evaluation.

resultsThe CatBoost model demonstrated superior performance, achieving an AUC of 0.8486 (95% CI: 0.8124-0.8797) on the test set and 0.8511 (95% CI: 0.8203-0.8793) on the validation set. Shapley Additive Explanations (SHAP) analysis identified the Charlson Comorbidity Index (CCI), length of stay (LOS), and treatment types as the most influential predictors. Notably, compared to the best existing literature, which reported an AUC of 0.760 on the test set, our model exhibited a 9% improvement in predictive performance while utilizing a more parsimonious feature set.

conclusionBy integrating four feature selection methods, we significantly streamlined the feature set, resulting in a more efficient and reliable predictive model. We propose the CatBoost model for the prediction of postoperative stroke in patients with CAD undergoing coronary revascularization. With its high accuracy, the proposed model offers valuable insights for medical practitioners, enabling informed decision-making and the implementation of preventive measures to mitigate stroke risk.

Indexed as

Coronary Artery BypassCoronary Artery DiseaseMachine LearningPercutaneous Coronary InterventionPostoperative ComplicationsStrokeAgedFemaleHumansMaleMiddle AgedRisk AssessmentCatBoost algorithmFeature selectionMachine learningRevascularized CAD patientsSHAP analysisStroke risk prediction

Identifiers

PMID40707947
PMCPMC12291392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.